Key facts
- This page summarizes David A. Urbanek's Form 4 filing for Elanco Animal Health Inc (ELAN).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 06 Mar 2023, 17:52.
David A. Urbanek - 02 Mar 2023 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)
- Reporting relationship
- Executive Vice President, Manufacturing and Quality
- Issuer ticker
- ELAN
- Reported as of
- 02 Mar 2023
- Net transaction value
- -$160,647
- SEC form
- 4
- Accepted by SEC
- 06 Mar 2023, 17:52:13 UTC
- Prior SEC filing
- 03 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Catherine S. Powell, as Attorney-in-Fact for David A. Urbanek
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David A. Urbanek filed Form 4 for Elanco Animal Health Inc (ELAN) on 06 Mar 2023.
Change
- Previous filing in this sequence was filed on 03 Mar 2023.
- Current net transaction value: -$160,647.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELAN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +33,502
- Change %
- +29%
- Price
- $0.000000
- Shares after
- 147,885
- Date
- 02 Mar 2023
- Ownership
- Direct
ELAN
transaction
Common Stock
Tax liability
- Transaction value
- $160,647
- Shares
- -14,591
- Change %
- -9.9%
- Price
- $11.01
- Shares after
- 133,294
- Date
- 02 Mar 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Executive Vice President, Manufacturing and Quality